[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CO6970602A2 - Inhibidores de quinasa - Google Patents

Inhibidores de quinasa

Info

Publication number
CO6970602A2
CO6970602A2 CO14121392A CO14121392A CO6970602A2 CO 6970602 A2 CO6970602 A2 CO 6970602A2 CO 14121392 A CO14121392 A CO 14121392A CO 14121392 A CO14121392 A CO 14121392A CO 6970602 A2 CO6970602 A2 CO 6970602A2
Authority
CO
Colombia
Prior art keywords
kinase inhibitors
kinase
inhibitors
Prior art date
Application number
CO14121392A
Other languages
English (en)
Inventor
Niel Monique Bodil Van
Nicholas Charles Ray
Lilian Alcaraz
Terry Aaron Panchal
Andrew Stephen Jennings
Elisabetta Armani
Andrew Peter Cridland
Christopher Hurley
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47471708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6970602(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of CO6970602A2 publication Critical patent/CO6970602A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/02—Formic acid
    • C07C53/06—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CO14121392A 2011-12-09 2014-06-05 Inhibidores de quinasa CO6970602A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11192871 2011-12-09
EP12187931 2012-10-10

Publications (1)

Publication Number Publication Date
CO6970602A2 true CO6970602A2 (es) 2014-06-13

Family

ID=47471708

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14121392A CO6970602A2 (es) 2011-12-09 2014-06-05 Inhibidores de quinasa

Country Status (35)

Country Link
US (5) US8907094B2 (es)
EP (1) EP2788349B1 (es)
JP (1) JP6128449B2 (es)
KR (1) KR101994381B1 (es)
CN (3) CN105968110B (es)
AR (1) AR089189A1 (es)
AU (1) AU2012347350C1 (es)
BR (1) BR112014013760A2 (es)
CA (1) CA2858447C (es)
CL (1) CL2014001486A1 (es)
CO (1) CO6970602A2 (es)
CY (1) CY1118340T1 (es)
DK (1) DK2788349T3 (es)
EA (1) EA025268B1 (es)
ES (1) ES2612259T3 (es)
GE (1) GEP201706735B (es)
HK (2) HK1200828A1 (es)
HR (1) HRP20161714T1 (es)
HU (1) HUE029826T2 (es)
IL (1) IL232958A (es)
LT (1) LT2788349T (es)
ME (1) ME02624B (es)
MX (1) MX359200B (es)
MY (1) MY170656A (es)
PE (1) PE20141370A1 (es)
PH (1) PH12014501277A1 (es)
PL (1) PL2788349T3 (es)
PT (1) PT2788349T (es)
RS (1) RS55602B1 (es)
SG (1) SG11201402985VA (es)
SI (1) SI2788349T1 (es)
TW (1) TWI618703B (es)
UA (1) UA115320C2 (es)
WO (1) WO2013083604A1 (es)
ZA (1) ZA201404156B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458154B2 (en) * 2011-12-09 2016-10-04 Chiesi Farmaceutici S.P.A. Kinase inhibitors
KR20140105459A (ko) * 2011-12-09 2014-09-01 키에시 파르마슈티시 엣스. 피. 에이. 키나아제 억제제
MY170656A (en) 2011-12-09 2019-08-24 Chiesi Farm Spa Kinase inhibitors
GB201214750D0 (en) 2012-08-17 2012-10-03 Respivert Ltd Compounds
US9783556B2 (en) 2012-08-29 2017-10-10 Respivert Limited Kinase inhibitors
US20150225373A1 (en) 2012-08-29 2015-08-13 Respivert Limited Kinase inhibitors
WO2014033446A1 (en) 2012-08-29 2014-03-06 Respivert Limited Kinase inhibitors
US9732063B2 (en) 2012-11-16 2017-08-15 Respivert Limited Kinase inhibitors
WO2014140582A1 (en) 2013-03-14 2014-09-18 Respivert Limited Kinase inhibitors
ES2856902T3 (es) 2013-04-02 2021-09-28 Oxular Acquisitions Ltd Derivados de urea útiles como inhibidores de quinasa
EP2981534B1 (en) 2013-04-02 2017-07-19 Topivert Pharma Limited Kinase inhibitors based upon n-alkyl pyrazoles
WO2014194956A1 (en) * 2013-06-06 2014-12-11 Chiesi Farmaceutici S.P.A. Derivatives of [1, 2, 4] triazolo [4, 3 - a] pyridine as p38 - map kinase inhibitors
EP3004098B1 (en) * 2013-06-06 2017-08-09 Chiesi Farmaceutici S.p.A. Kinase inhibitors
CA2914432A1 (en) 2013-06-06 2014-12-11 Chiesi Farmaceutici S.P.A. Kinase inhibitors
EP2818471A1 (en) * 2013-06-27 2014-12-31 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5
CN106029651A (zh) 2013-12-20 2016-10-12 瑞斯比维特有限公司 用作激酶抑制剂的脲衍生物
PL3357919T3 (pl) 2014-02-14 2020-06-01 Respivert Limited Aromatyczne związki heterocykliczne jako związki przeciwzapalne
MA40775A (fr) 2014-10-01 2017-08-08 Respivert Ltd Dérivé d'acide 4-(4-(4-phényluréido-naphtalén -1-yl) oxy-pyridin-2-yl) amino-benzoïque utilisé en tant qu'inhibiteur de la kinase p38
US10206949B2 (en) 2015-09-21 2019-02-19 Ofer Agam Composition that relieves heartburn, GERD and hangovers
EP3394060A1 (en) 2015-12-23 2018-10-31 Chiesi Farmaceutici S.p.A. 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urea derivatives and their use as p38 mapk inhibitors
EP3394059B1 (en) 2015-12-23 2020-11-25 Chiesi Farmaceutici S.p.A. 1-(3-tert-butyl-phenyl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro- naphthalen-1-yl)-urea derivatives and their use as p38 mapk inhibitors
AR107163A1 (es) 2015-12-23 2018-03-28 Chiesi Farm Spa Inhibidores de quinasa
CN109071505B (zh) 2016-04-06 2021-11-16 奥苏拉收购有限公司 激酶抑制剂
US10364245B2 (en) * 2017-06-07 2019-07-30 Chiesi Farmaceutici S.P.A. Kinase inhibitors
KR20200066655A (ko) 2017-10-05 2020-06-10 풀크럼 쎄러퓨틱스, 인코포레이티드 DUX4의 발현을 저감시키기 위한 p38 저해제의 용도
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CN108424372B (zh) * 2018-05-11 2021-08-10 浙江华贝药业有限责任公司 2，2，2-三氟-n-[(s)-4-羰基四氢萘-1-基]-乙酰胺的纯化工艺
CN108707086B (zh) * 2018-05-15 2021-08-10 浙江华贝药业有限责任公司 一种(1s，4s)-n-（4-羟基四氢萘-1-基）叔丁氧基碳酰胺的纯化工艺
AR116628A1 (es) 2018-10-18 2021-05-26 Syngenta Crop Protection Ag Compuestos microbiocidas
US20230131427A1 (en) 2020-03-05 2023-04-27 Syngenta Crop Protection Ag Fungicidal compositions
CN112174870B (zh) * 2020-10-12 2023-07-21 蔡霈 (r)-1-烷烃酰基-2-取代吡咯烷-2-甲酰胺的制备方法及其药用用途

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5756533A (en) 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
JPH11508583A (ja) 1995-07-06 1999-07-27 ゼネカ・リミテッド ペプチド系のフィブロネクチン阻害薬
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
YU25500A (sh) 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
GB0028383D0 (en) 2000-11-21 2001-01-03 Novartis Ag Organic compounds
EP1241176A1 (en) 2001-03-16 2002-09-18 Pfizer Products Inc. Purine derivatives for the treatment of ischemia
WO2002083628A1 (en) * 2001-04-13 2002-10-24 Boehringer Ingelheim Pharmaceuticals, Inc. 1,4-disubstituted benzo-fused compounds
US7199136B2 (en) 2001-12-20 2007-04-03 Bayer Healthcare Ag 1,4-dihydro-1,4-diphenylpyridine derivatives
EP1549621A1 (en) * 2002-08-08 2005-07-06 Boehringer Ingelheim Pharmaceuticals Inc. Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes
EP1601672B1 (en) * 2003-02-14 2006-07-26 Pfizer Products Inc. Triazolo-pyridines as anti-inflammatory compounds
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
JP5097539B2 (ja) * 2004-05-07 2012-12-12 アムジエン・インコーポレーテツド タンパク質キナーゼ調節剤および使用方法
ATE400567T1 (de) 2004-06-23 2008-07-15 Lilly Co Eli Kinaseinhibitoren
EP1609789A1 (en) 2004-06-23 2005-12-28 Eli Lilly And Company Ureido-pyrazole derivatives and their use as kinase inhibitors
GB0418015D0 (en) * 2004-08-12 2004-09-15 Pfizer Ltd New compounds
DE602005010714D1 (de) 2004-08-12 2008-12-11 Pfizer Der p38-map-kinase
EP1781655A2 (en) 2004-08-18 2007-05-09 Pharmacia & Upjohn Company LLC Triazolopyridine compounds useful for the treatment of inflammation
GB0502258D0 (en) 2005-02-03 2005-03-09 Argenta Discovery Ltd Compounds and their use
CA2610509A1 (en) 2005-06-03 2006-12-14 Bayer Healthcare Ag 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
EP1984363A1 (en) 2006-02-09 2008-10-29 Pfizer Limited Triazolopyridine compounds
CN101146029B (zh) * 2006-09-13 2011-12-28 华为技术有限公司 一种分组重排序方法和系统
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
AR063141A1 (es) 2006-10-04 2008-12-30 Pharmacopeia Inc Derivados de 2- ( benzimidazolil ) purina 8- sustituida para inmunosupresion
JP2010505855A (ja) 2006-10-06 2010-02-25 アボット・ラボラトリーズ 新規なイミダゾチアゾール類およびイミダゾオキサゾール類
CN101636397B (zh) 2007-04-13 2012-06-13 中国人民解放军军事医学科学院毒物药物研究所 脲类化合物、其制备方法及其医药用途
US8202899B2 (en) 2007-07-25 2012-06-19 Array Biopharma Inc. Pyrazole urea derivatives used as kinase inhibitors
US20110207729A1 (en) 2007-08-10 2011-08-25 Astellas Pharma Inc. Bicyclic acylguanidine derivative
TWI496779B (zh) 2008-08-19 2015-08-21 Array Biopharma Inc 作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
SG10201707798SA (en) 2008-12-08 2017-10-30 Gilead Connecticut Inc Imidazopyrazine syk inhibitors
WO2010067131A1 (en) * 2008-12-11 2010-06-17 Respivert Limited P38 map kinase inhibitors
US8629157B2 (en) 2009-01-05 2014-01-14 Boehringer Ingelheim International Gmbh Pyrrolidine compounds which modulate the CB2 receptor
JP2012517992A (ja) 2009-02-17 2012-08-09 チェシ ファーマスーティシ エス．ピー．エイ． Ｐ３８ｍａｐキナーゼインヒビターとしてのトリアゾロピリジン誘導体
WO2010108058A2 (en) 2009-03-20 2010-09-23 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Small molecule inhibitors of dusp6 and uses therefor
US8721380B2 (en) 2009-08-12 2014-05-13 Konica Minolta Holdings, Inc. Method for manufacturing display panel
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
GB0921731D0 (en) 2009-12-11 2010-01-27 Respivert Ltd Theraputic uses
GB201005589D0 (en) * 2010-04-01 2010-05-19 Respivert Ltd Novel compounds
WO2011124930A1 (en) * 2010-04-08 2011-10-13 Respivert Limited P38 map kinase inhibitors
GB201009731D0 (en) * 2010-06-10 2010-07-21 Pulmagen Therapeutics Inflamma Kinase inhibitors
KR20140105459A (ko) 2011-12-09 2014-09-01 키에시 파르마슈티시 엣스. 피. 에이. 키나아제 억제제
MY170656A (en) 2011-12-09 2019-08-24 Chiesi Farm Spa Kinase inhibitors
US9458154B2 (en) 2011-12-09 2016-10-04 Chiesi Farmaceutici S.P.A. Kinase inhibitors
WO2014194956A1 (en) 2013-06-06 2014-12-11 Chiesi Farmaceutici S.P.A. Derivatives of [1, 2, 4] triazolo [4, 3 - a] pyridine as p38 - map kinase inhibitors
EP3004098B1 (en) 2013-06-06 2017-08-09 Chiesi Farmaceutici S.p.A. Kinase inhibitors
CA2914432A1 (en) 2013-06-06 2014-12-11 Chiesi Farmaceutici S.P.A. Kinase inhibitors

Also Published As

Publication number Publication date
US20150344475A1 (en) 2015-12-03
PH12014501277B1 (en) 2014-09-08
KR20140105516A (ko) 2014-09-01
TW201336833A (zh) 2013-09-16
HK1222647A1 (zh) 2017-07-07
US9139584B2 (en) 2015-09-22
IL232958A (en) 2017-08-31
ZA201404156B (en) 2016-07-27
MY170656A (en) 2019-08-24
AU2012347350B2 (en) 2016-09-08
CN104039787A (zh) 2014-09-10
HRP20161714T1 (hr) 2017-02-10
US20150080375A1 (en) 2015-03-19
US8907094B2 (en) 2014-12-09
CN105503861A (zh) 2016-04-20
RS55602B1 (sr) 2017-06-30
JP2015500260A (ja) 2015-01-05
CN105503861B (zh) 2017-08-01
SG11201402985VA (en) 2014-08-28
NZ625965A (en) 2016-08-26
US9145413B2 (en) 2015-09-29
US20160229852A1 (en) 2016-08-11
CN104039787B (zh) 2016-06-29
HK1200828A1 (en) 2015-08-14
EA025268B1 (ru) 2016-12-30
JP6128449B2 (ja) 2017-05-17
PE20141370A1 (es) 2014-10-17
ES2612259T3 (es) 2017-05-16
EP2788349A1 (en) 2014-10-15
IL232958A0 (en) 2014-08-03
EP2788349B1 (en) 2016-10-26
ME02624B (me) 2017-06-20
CA2858447C (en) 2020-10-27
CN105968110B (zh) 2018-04-27
AR089189A1 (es) 2014-08-06
MX359200B (es) 2018-09-19
US20140323470A1 (en) 2014-10-30
BR112014013760A2 (pt) 2017-06-13
PT2788349T (pt) 2017-02-02
PL2788349T3 (pl) 2017-04-28
KR101994381B1 (ko) 2019-06-28
SI2788349T1 (sl) 2017-01-31
MX2014006724A (es) 2014-08-29
PH12014501277A1 (en) 2014-09-08
LT2788349T (lt) 2016-12-27
GEP201706735B (en) 2017-09-25
UA115320C2 (uk) 2017-10-25
TWI618703B (zh) 2018-03-21
US20130150343A1 (en) 2013-06-13
US9527846B2 (en) 2016-12-27
DK2788349T3 (en) 2017-01-30
CL2014001486A1 (es) 2014-11-14
WO2013083604A1 (en) 2013-06-13
CA2858447A1 (en) 2013-06-13
HUE029826T2 (en) 2017-04-28
US9315503B2 (en) 2016-04-19
CN105968110A (zh) 2016-09-28
AU2012347350C1 (en) 2017-01-19
EA201490949A1 (ru) 2014-11-28
AU2012347350A1 (en) 2014-07-03
CY1118340T1 (el) 2017-06-28

Similar Documents

Publication Publication Date Title
CO6970602A2 (es) Inhibidores de quinasa
DK2710007T3 (da) Kinasehæmmere
CO6950481A2 (es) Inhibidores de proteínas quinasas
DK2903618T3 (da) Rho-kinase-inhibitorer
DK2895484T3 (da) Glucosylceramidsynthase-inhibitorer
CO6801749A2 (es) Inhibidores de glucosilceramida sintasa
BR112014003214A2 (pt) polimorfos inibidores de cinase
SMT201600114B (it) Inibitori di beta-secretasi
BR112014000653A2 (pt) inibidores de tirosina quinase de bruton
BR112013029620A2 (pt) inibidores de tirosina quinase de bruton
DK3181567T3 (da) Pyrazolopyrimidinforbindelser som kinasehæmmere
CR20120576A (es) Inhibidores de pirazolil quinazolina cinasa
BR112013030095A2 (pt) inibidores de atividade de lrrk2 cinase
CO6880068A2 (es) Aminoquinazolinas como inhibidores de quinasa
CU24164B1 (es) Inhibidores sustituidos de acetil-coa carboxilasa
IL228103A0 (en) Amino-quinolines as kinase inhibitors
CO6890101A2 (es) Inhibidores de pde10 de pirimidina
DK2917210T3 (da) Alk kinase-inhibitorer
BR112013025761A2 (pt) inibidores de hsp90
IL229028A0 (en) Kinase inhibitors
EP2685992A4 (en) AMINO-QUINOLINES AS KINASE INHIBITORS
CO6990735A2 (es) Inhibidores de pirazina cinasa
HK1199873A1 (en) Kinase inhibitors
BR112014001977A2 (pt) inibidores seletivos de proteína quinase
BR112014001965A2 (pt) di-cloridrato de denibulin